Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 13, 2017 - Issue
Submit an article Journal homepage
79
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial

Taro Kishi1 Department of Psychiatry, Fujita Health University School of MedicineCorrespondence[email protected]
,
Yuki Matsuda1 Department of Psychiatry, Fujita Health University School of Medicine
,
Shinji Matsunaga1 Department of Psychiatry, Fujita Health University School of Medicine
,
Masatsugu Moriwaki1 Department of Psychiatry, Fujita Health University School of Medicine;2 Department of Psychiatry, Okehazama Hospital, Toyoake
,
Yoichiro Otake2 Department of Psychiatry, Okehazama Hospital, Toyoake
,
Kaku Akamatsu3 Department of Psychiatry, Jindai Clinic, Nagoya
,
Tomo Okochi4 Department of Psychiatry, Toyota Memorial Hospital
,
Shigeki Hirano4 Department of Psychiatry, Toyota Memorial Hospital
,
Toshihiko Funahashi5 Department of Psychiatry, Jindai Hospital, Toyota, Aichi
,
Momoko Okuda6 Department of Psychiatry, Holy Cross Hospital, Toki, Gifu, Japan
,
Hideaki Tabuse6 Department of Psychiatry, Holy Cross Hospital, Toki, Gifu, Japan
,
Kiyoshi Fujita2 Department of Psychiatry, Okehazama Hospital, Toyoake
&
Nakao Iwata1 Department of Psychiatry, Fujita Health University School of Medicine
 show all
Pages 117-125 | Published online: 06 Jan 2017

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Tempei Otsubo, Yoshinori Watanabe, Seiji Hongo, Mikichika Inoue, Kimiko Akimoto, Ken Murakami, Ryutaro Takahashi & Toshiaki Kikuchi. (2018) Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study. Neuropsychiatric Disease and Treatment 14, pages 955-966.
Read now

Articles from other publishers (2)

Madhavi Kodali, Srikanth Lella, Sarath Bodepudi, Therissa Benerji & Krishna Mohan Parvathaneni. (2021) Effectiveness and side-effect profile of Vilazodone and Escitalopram in major Depressive Disorder – An observational study. IP Indian Journal of Neurosciences 7:1, pages 20-25.
Crossref
Aron Tendler, Roman Gersner, Yiftach Roth & Abraham Zangen. (2018) Alternate day dTMS combined with SSRIs for chronic treatment resistant depression: A prospective multicenter study. Journal of Affective Disorders 240, pages 130-136.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.